pioneering

progress

We are

Vonvascular.io is a disruptive MedTech company with a focused mission: to transform lives through disruptive technology that makes thrombectomy better.

Our commitment extends beyond innovation; it’s about doing what right for the patient, the physician and the planet. We empower customers to choose the tools and techniques that work best in their hands, aiming not just to support but to elevate their impact.

At vonvascular.io, we’re not just changing procedures. We’re transforming lives, responsibly.

We are hyper-focused on

what we

do best.

Neurovascular

thrombectomy

Peripheral

thrombectomy

Pulmonary

thrombectomy

catalysts 

of change.

We are the

At vonvascular.io, our unwavering commitment is to redefine the landscape of thrombectomy through innovative medical devices that target and conquer the challenges intrinsic to thrombectomy procedures. We are a team of physicians, researchers, and engineers with a passion for transforming lives and a continuous drive to push the boundaries of technology, knowledge, and care.

Manning Hanser 

CEO

Rob Slazas

Head of R&D

Authenticity

is our cornerstone.

We are a diverse team with an expansive background. Step into our world for a glimpse into the expanse of our collective exprtise!

Community
Unlocking the Potential of First Pass Efficacy in Stroke Thrombectomy
Unlocking the Potential of First Pass Efficacy in Stroke Thrombectomy

When it comes to stroke care, time is brain. Every minute lost equates to millions of neurons dying, and the repercussions on a patient's quality of life can be profound. In the pursuit of minimizing these neurological deficits, innovations in stroke thrombectomy devices and techniques are paramount. Among these, the concept of First Pass Efficacy (FPE) and the integration of cyclic aspiration hold significant promise.

Read More →

Join the conversation.